Ani Pharmaceuticals Inc (ANIP)
Ani Pharmaceuticals stock today
Ani Pharmaceuticals closed at $72.00 on October 30, 2026, down 1.59% on the day. Over the past year it returned -21.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.64 billion.
| Period | ANIP | S&P 500 (SPY) |
|---|---|---|
| 1 month | -0.9% | -0.9% |
| 3 months | -10.5% | +2.1% |
| Year to date | -8.8% | +11.7% |
| 1 year | -21.7% | +12.4% |
| 3 years | +19.0% | +88.5% |
| 5 years | +92.6% | +76.0% |
Key statistics
- Market value
- $1.64B
- P/E (trailing)
- 15.7
- Forward P/E
- 7.4
- Price / sales
- 1.7
- 52-week range
- $70.16 to $94.48
- Next report
- Nov 5, 2026
About Ani Pharmaceuticals
Manufactures and sells generic pharmaceuticals and specialty branded medications.
Sector: Health Care
More on Ani Pharmaceuticals
- Financials: revenue, earnings and segmentsRevenue +44% in the year to Dec 2025
- Valuation: P/E history and peersP/E 15.7, median 64.9 at its last 5 year ends
- Returns: what $1,000 became$1,000 ten years ago is $1,194 today
No forecast, no recommendation. This page describes Ani Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.